Simple method for quantitative measuring the adhesion of platelets ex vivo

• US 7,485,472 B2
• Filed: 08/09/2001
• Issued: 02/03/2009
• Est. Priority Date: 08/09/2000
• Status: Expired due to Fees

• Current Assignee: JenAffin GmbH
• Original Assignee: JenAffin GmbH
• Inventors: Nowak, Gotz, Bucha, Elke
• Primary Examiner(s): GABEL, GAILENE
• Application Number:
  US10/344,359
• Publication Number:
  US 20040029193A1
• Time in Patent Office: 2,735 Days
• Field of Search: 435/2, 435/7.21, 435/286.5, 435/286.7, 436523-534, 436/539, 436/10, 436/17, 436/18, 436/63, 436/69, 436/165, 422/73
• US Class Current: 436/529
• CPC Class Codes: G01N 33/86 involving blood coagulating time or factors, or their receptors
• CPC Class Codes: Y10T 436/101666 Particle count or volume standard or control [e.g., platelet count standards, etc.]
• CPC Class Codes: Y10T 436/107497 Preparation composition [e.g., lysing or precipitation, etc.]
• CPC Class Codes: Y10T 436/108331 Preservative, buffer, anticoagulant or diluent

Abstract

The invention relates to measuring of the adhesion of platelets ex vivo. In this method, monodisperse polymer particles are added to blood, and the number of platelets in the blood are measured before and after shaking of the sample. The level of adhesion of the platelets is determined by comparing the number of platelets prior to shaking with the number of platelets after shaking. Methods of establishing an adhesion index and diagnosis of a patient are also provided.

Claims

1. A diagnostic method for measuring the adhesion of platelets ex vivo comprising

a) selecting an amount and type of monodisperse polymer particles derived from at least one artificial polymer;

b) providing a sample of whole blood;

c) adding said monodisperse polymer particles to the sample of whole blood to form a blood/polymer particles composition;

d) measuring the number of platelets in the whole blood/polymer particles composition;

f) shaking the whole blood/polymer particles composition to allow platelets in the whole blood to adhere directly to the surface of the polymer particles;

g) measuring the number of platelets in the whole blood/polymer particles composition after shaking that remain in suspension in the composition; and

h) determining the percent level of adhesion of the platelets by comparing the number of platelets in suspension prior to shaking with the number of platelets in suspension after shaking.

2. The method of claim 1, wherein the artificial polymer is polyphenylmethacrylate.

3. The method of claim 2, wherein the artificial polymer is porous.

4. The method of claim 1 wherein the polymer particles have a diameter of 1 to 20 μ

m.

5. The method of claim 4 wherein the diameter is 1 to 10 μ

m.

6. The method of claim 5 wherein the diameter is 5 to 6 μ

m.

7. The method of claim 1, wherein the measuring step is a step in a process of carrying out a diagnosis of increased or reduced adhesivity of platelets, ex vivo.

8. The method of claim 1, wherein the measuring step is a step in a process of monitoring the effect of substances inhibiting platelet function in the whole blood of a patient.

9. The method of claim 1, wherein the measuring step is a step in a process of monitoring the effect of GPIIb/IIIa receptor antagonists on platelet function in the whole blood of a patient.

10. The method of claim 1, wherein prior to the adding polymer particles step, the whole blood has been treated with an anticoagulant.

11. The method of claim 1, wherein prior to the adding polymer particles step, the whole blood has been treated with a GPIIb/IIIa receptor antagonist.

12. The method of claim 1, wherein the measurement of the number of platelets in suspension is carried out by using a blood cell counting device.